gabapentin

Generic: gabapentin

Labeler: advagen pharma ltd
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name gabapentin
Generic Name gabapentin
Labeler advagen pharma ltd
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

gabapentin 250 mg/5mL

Manufacturer
Advagen Pharma Ltd

Identifiers & Regulatory

Product NDC 72888-104
Product ID 72888-104_4b921bb1-ab2e-af6a-e063-6294a90a0694
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA216492
Listing Expiration 2027-12-31
Marketing Start 2023-01-18

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72888104
Hyphenated Format 72888-104

Supplemental Identifiers

RxCUI
283523
UPC
0372888104256
UNII
6CW7F3G59X
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name gabapentin (source: ndc)
Generic Name gabapentin (source: ndc)
Application Number ANDA216492 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/5mL
source: ndc
Packaging
  • 470 mL in 1 BOTTLE (72888-104-25)
source: ndc

Packages (1)

Ingredients (1)

gabapentin (250 mg/5mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4b921bb1-ab2e-af6a-e063-6294a90a0694", "openfda": {"nui": ["N0000008486"], "upc": ["0372888104256"], "unii": ["6CW7F3G59X"], "rxcui": ["283523"], "spl_set_id": ["bfee67dc-d2b1-4a00-92d9-a42be3189c74"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Advagen Pharma Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "470 mL in 1 BOTTLE (72888-104-25)", "package_ndc": "72888-104-25", "marketing_start_date": "20230612"}], "brand_name": "Gabapentin", "product_id": "72888-104_4b921bb1-ab2e-af6a-e063-6294a90a0694", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "72888-104", "generic_name": "gabapentin", "labeler_name": "Advagen Pharma Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "250 mg/5mL"}], "application_number": "ANDA216492", "marketing_category": "ANDA", "marketing_start_date": "20230118", "listing_expiration_date": "20271231"}